Armistice Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,200,000
| Closed | -$9.57M | – | 358 |
|
2023
Q4 | $9.57M | Buy |
+3,200,000
| New | +$9.57M | 0.13% | 89 |
|
2023
Q3 | – | Sell |
-9,193,000
| Closed | -$12.8M | – | 258 |
|
2023
Q2 | $12.8M | Buy |
9,193,000
+5,513,721
| +150% | +$7.66M | 0.18% | 80 |
|
2023
Q1 | $5.85M | Buy |
+3,679,279
| New | +$5.85M | 0.08% | 101 |
|